00:00 / 00:00
Macrocytic anemia: Pathology review
Microcytic anemia: Pathology review
Extrinsic hemolytic normocytic anemia: Pathology review
Thrombocytopenia: Clinical (To be retired)
Platelet disorders: Pathology review
Polycythemia vera (NORD)
Blood groups and transfusions
Platelet plug formation (primary hemostasis)
Iron deficiency anemia
Anemia of chronic disease
Autoimmune hemolytic anemia
Paroxysmal nocturnal hemoglobinuria
Pyruvate kinase deficiency
Vitamin B12 deficiency
Folate (Vitamin B9) deficiency
Antithrombin III deficiency
Factor V Leiden
Protein C deficiency
Protein S deficiency
Essential thrombocythemia (NORD)
Lymphomas: Pathology review
Leukemias: Pathology review
Myeloproliferative disorders: Pathology review
Subacute granulomatous thyroiditis
0 / 12 complete
0 / 2 complete
Tanner Marshall, MS
Kaia Chessen, MScBMC
In antiphospholipid syndrome, individuals produce antiphospholipid antibodies, which attack the phospholipids in the cell membrane of their own cells, or attack proteins that are bound to those phospholipids.
So antiphospholipid syndrome, or APS, is an autoimmune disease.
Antiphospholipid syndrome can be primary or secondary. Primary antiphospholipid syndrome occurs by itself, whereas secondary antiphospholipid syndrome occurs with other autoimmune diseases, especially systemic lupus erythematosus.
And just like most autoimmune diseases, antiphospholipid syndrome is more common in young females.
The exact cause of antiphospholipid syndrome isn’t known, but there are some known genetic and environmental factors.
For instance, the HLA-DR7 gene encodes a specific type of a protein called major histocompatibility complex or MHC class II, which sits on the surface of the B cell.
These surface proteins help activate B cells so that they can start producing antibodies.
Now, having a mutated HLA-DR7 gene predisposes individuals to activate B cell production of antiphospholipid antibodies.
But the presence of the mutated HLA-DR7 gene alone isn’t enough to develop antiphospholipid syndrome - an environmental trigger must also be present.
There’s a variety of potential triggers - some common ones include infections - like syphilis, hepatitis C, HIV, and malaria - drugs, like some cardiovascular drugs - including procainamide, quinidine, propranolol, and hydralazine - or antipsychotic drugs like phenytoin and chlorpromazine.
Copyright © 2023 Elsevier, except certain content provided by third parties
Cookies are used by this site.
USMLE® is a joint program of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). COMLEX-USA® is a registered trademark of The National Board of Osteopathic Medical Examiners, Inc. NCLEX-RN® is a registered trademark of the National Council of State Boards of Nursing, Inc. Test names and other trademarks are the property of the respective trademark holders. None of the trademark holders are endorsed by nor affiliated with Osmosis or this website.